Immunic, Inc. (IMUX) vs Lucid Diagnostics Inc. (LUCD)
A side-by-side comparison of Immunic, Inc. and Lucid Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMUX
Immunic, Inc.
$7.82HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
LUCD
Lucid Diagnostics Inc.
$0.60HealthcareDelayed quote: Oct 6, 2026, 10:39 AM EDT
Total return — IMUX vs LUCD
growth of $100 · dividends reinvested · last 5yIMUX -90.1% (-37.0%/yr)LUCD -95.0% (-45.0%/yr)IMUX compounded faster over this window
IMUX LUCD
IMUX vs LUCD: by the numbers
- •LUCD is the larger company ($114M vs $107M market cap).
- •Both run net losses; IMUX's is the smaller (0.00% vs -959.76% net margin).
Metrics side by side
Valuation
| Metric | IMUX | LUCD |
|---|---|---|
| P/S ratio | N/A | 20.98 |
| P/B ratio | 0.84 | 10.45 |
Profitability
| Metric | IMUX | LUCD |
|---|---|---|
| Gross margin | 0.00% | -60.26% |
| Operating margin | 0.00% | -1054.82% |
| Net margin | 0.00% | -959.76% |
| ROE | -87.45% | -478.26% |
| ROIC | -92.16% | -145.10% |
Growth (annualized)
| Metric | IMUX | LUCD |
|---|---|---|
| Total return CAGR (5Y) | -35.70% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.